"The Company believes that the current volatility in the share price may be as a result of this."www.galaxyresources.com.au/documents/DOCGXYLithium...ransferCompleted.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%